Clients

Adamis Pharmaceuticals Corp

Company Snapshot: Adamis Pharmaceuticals Corp

ADMP
Last Change Volume High Low

Company Overview

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology. In its specialty pharmaceutical pipeline, ADMP is developing low cost therapeutic alternatives for the treatment of anaphylaxis, asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. Within the Company's biotechnology pipeline is a novel cell-based therapeutic cancer vaccine and three drug candidates for the treatment of prostate cancer.

Client News

  1. Feb 21 2020 Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
  2. Feb 19 2020 Adamis Pharmaceuticals Provides Update Regarding ZIMHI
  3. Dec 19 2019 Adamis Pharmaceuticals Provides an Update on ZIMHI
  4. Dec 19 2019 Adamis Pharmaceuticals Provides an Update on ZIMHI
  5. Nov 25 2019 Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI